Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 24, 2016

Primary Completion Date

January 30, 2017

Study Completion Date

April 4, 2017

Conditions
Infertility
Interventions
DEVICE

Diafert

The Diafert output, the G-CSF concentration in FF, will be recorded but will not be used in patient management.

Trial Locations (9)

19010

Main Line Fertility Center, Bryn Mawr

33759

Women's Medical Research Group, Clearwater

45209

Institute for Reproductive Health, Cincinnati

60169

InVia Fertility Specialists, Hoffman Estates

75231

Dallas - Fort Worth Fertility Associates, Dallas

77063

Houston Fertility Institute, Houston

84062

Utah Fertiity Center, Pleasant Grove

84092

Reproductive Care Center, Sandy City

91436

Huntington Reproductive Center, Encino

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY